StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

MariMed's pe ratio was 16.4× on Oct 31, 2023, against 27.5× a year earlier. Over the last 3 years it ranged from 9.6× to 260.0×, with a median of 39.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 202316.4×−38.3
2022Dec 30, 202254.7×+11.4
2021Dec 31, 202143.3×−216.8
2018Jan 31, 2018260.0×+122.0
2017Dec 29, 2017138.0×–

More MariMed figures

See a number that looks wrong?